These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 20547915)

  • 1. Does age modify effectiveness of statin therapy in coronary artery disease?
    Pletcher MJ; Coxson PG
    Ann Intern Med; 2010 Jun; 152(12):825; author reply 825-6. PubMed ID: 20547915
    [No Abstract]   [Full Text] [Related]  

  • 2. Appropriateness of statins in patients aged ≥80 years and comparison to other age groups.
    Chokshi NP; Messerli FH; Sutin D; Supariwala AA; Shah NR
    Am J Cardiol; 2012 Nov; 110(10):1477-81. PubMed ID: 22901970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy for prevention of coronary artery disease. The earlier the better or the longer the better?
    Holdaas H
    Eur Heart J; 2008 Feb; 29(4):425-6. PubMed ID: 18276612
    [No Abstract]   [Full Text] [Related]  

  • 4. Statin therapy in young adults: ready for prime time?
    Pletcher MJ; Hulley SB
    J Am Coll Cardiol; 2010 Aug; 56(8):637-40. PubMed ID: 20705221
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of a global risk educational tool on primary coronary prevention: the Atherosclerosis Assessment Via Total Risk (AVIATOR) study.
    Jacobson TA; Gutkin SW; Harper CR
    Curr Med Res Opin; 2006 Jun; 22(6):1065-73. PubMed ID: 16846539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention.
    Smith ER
    Can J Cardiol; 2004 Nov; 20(13):1373-4. PubMed ID: 15565204
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary risk prevention in the elderly: use clinician-patient discussions, not automatic statin prescribing.
    Stone NJ; Blum CB
    Am J Med; 2015 Aug; 128(8):804-6. PubMed ID: 25820167
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum plant sterols and atherosclerosis: is there a place for statin-ezetimibe combination?
    Radermecker RP; Scheen AJ
    J Am Coll Cardiol; 2006 Apr; 47(7):1496-7; author reply 1497-8. PubMed ID: 16580546
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimizing statin treatment for primary prevention of coronary artery disease.
    Hayward RA; Krumholz HM; Zulman DM; Timbie JW; Vijan S
    Ann Intern Med; 2010 Jan; 152(2):69-77. PubMed ID: 20083825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
    Seshasai SR; Ray KK
    Future Cardiol; 2009 Mar; 5(2):129-39. PubMed ID: 19371188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?
    Athyros VG; Tziomalos K; Karagiannis A; Wierzbicki AS; Mikhailidis DP
    Curr Opin Cardiol; 2010 Jul; 25(4):406-10. PubMed ID: 20375883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Celik M; Celik T
    Anadolu Kardiyol Derg; 2009 Jun; 9(3):253; author reply 253-4. PubMed ID: 19520663
    [No Abstract]   [Full Text] [Related]  

  • 13. Ask the doctors. I am 71 years old, have chronic kidney failure, and am on dialysis. I know my overall outlook is not good, and I wonder whether it is worth it to take a statin to control my cholesterol.
    Lee T; Lee R
    Harv Heart Lett; 2012 Dec; 23(4):2. PubMed ID: 23476941
    [No Abstract]   [Full Text] [Related]  

  • 14. Statin therapy in women: concerns and caution.
    Rosenberg H; Mascitelli L; Pezzetta F; Goldstein MR
    Int J Cardiol; 2010 Sep; 144(1):145-7. PubMed ID: 19168241
    [No Abstract]   [Full Text] [Related]  

  • 15. Statin use and prognosis in patients with advanced heart failure.
    Martínez-Sellés M; Domínguez M; Martínez E; García Fernández MA; García E
    Int J Cardiol; 2007 May; 118(1):135-7. PubMed ID: 16949689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosuvastatin: a highly potent statin for the prevention and management of coronary artery disease.
    Kapur NK
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):161-75. PubMed ID: 17338662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlling lipids in a high-risk population with documented coronary artery disease for secondary prevention: are we doing enough?
    Singh M; Chin SH; Giles PD; Crothers D; Al-Allaf K; Khan JM
    Eur J Cardiovasc Prev Rehabil; 2010 Oct; 17(5):556-61. PubMed ID: 20305563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and treatment: a tale of two strategies.
    Diamond GA; Kaul S
    J Am Coll Cardiol; 2008 Jan; 51(1):46-8. PubMed ID: 18174035
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
    Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
    Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary event secondary prevention with statins irrespective of LDL-cholesterol.
    Kerst LL; Mauro VF
    Ann Pharmacother; 2004 Jun; 38(6):1060-4. PubMed ID: 15121997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.